glp-1 drugs key developments 2025 2.0: Where the Next Wave of Value Will Be Created GLP-1 RA prescription trends: January

Previously, GLP-1 medications which mimic the naturally occurring hormone glucagon-like peptide-1, which regulates blood sugar, digestion, and hunger had been approved only to treat obesity in the form of weekly, home-administered injections

In contrast, Mittag-Roussou et al

GLP-1 medications, by contrast, may face supply shortages, require specialty pharmacy fulfillment, and involve navigating prior authorization processes that can delay treatment by weeks

Additionally, the GLP-1 agonist increases satiety, leading to fewer cravings and helping individuals make healthier food choices

To get started, fill out a quick survey to share more about your wellness history and weight loss goals